[Management of patients with benign prostatic hyperplasia by urologists: the DUO study] [0.03%]
良性前列腺增生患者泌尿科医师的管理方法-DUO研究
R O Fourcade,M C Picot,A F Gaudin et al.
R O Fourcade et al.
The DUO study intended to define the factors determining diagnostic and treatment strategies for benign prostatic hyperplasia (BPH) management. Methods: T...
D Chevallier,J Amiel
D Chevallier
Nowadays, taking into account the sexuality is an essential component of the management of prostate cancer patients. This implies the necessity for providing accurate, clear and transparent information about the potential adverse effects on...
E Haddad
E Haddad
Adjuvant bicalutamide monotherapy after radical prostatectomy improves the overall survival in patients with locally advanced prostate cancer. The main adverse event of the nonsteroidal antiandrogen is the development of gynecomastia agains...
R-O Fourcade
R-O Fourcade
The Early Prostate Cancer (EPC) Program consists of three randomised, double blind, placebo-controlled trials that assess bicalutamide either as adjuvant to treatment of curative intent or alone (radical prostatectomy, radiotherapy or watch...
Randomized Controlled Trial
Annales d'urologie. 2006 Dec:40 Suppl 2:S44-8. DOI:10.1016/s0003-4401(06)80020-3 2006
M Zerbib,F Richard
M Zerbib
[Difficult clinical cases in prostate cancer: multidisciplinary staff, the rational principles of adjuvant therapy and other therapeutic options] [0.03%]
前列腺癌疑难病例的多学科讨论及辅助治疗和其他治疗选择的合理原则
M Zerbib,K Fizazi,C Hennequin et al.
M Zerbib et al.
Difficult clinical cases of locally advanced prostate cancer at high-risk of progression should be discussed during a collegial decision-making process with different clinical specialists (surgeon, radiotherapist, oncologist, chemotherapist...
V Molinié
V Molinié
The examination by the pathologist of the whole prostate gland after radical prostatectomy allows close inspection of the tissue in order to determine the presence or absence of important prognostic pathological parameters, such as the hist...
X Rébillard
X Rébillard
Most of prostatic malignancies are adenocarcinomas. Nomograms using pretreatment clinical or pathological features predict the probability of biochemical or clinical relapse after radical prostatectomy. These predictive tools must not be us...
[Localized prostate cancer. Local treatment and what place for lymphadenectomy] [0.03%]
[局限性前列腺癌的局部治疗以及淋巴结清扫所处的地位]
D Rossi
D Rossi
The pretreatment PSA level, the Gleason score, the presence of lymph-node metastases, the status of surgical positive margins are poor pathological risk factors for patients who have a pathologic stage T3 prostate cancer. The increase in PS...
P Coloby
P Coloby
The first medical consultation with the urologist is the occasion to explain to the patient the importance of the initial PSA value, the periodic PSA measurements and the need of prostate biopsy for definitive confirmation. The next consult...